KAYYEM JON FAIZ purchased 35.6% of their position (286.79K shares) of INHIBRX BIOSCIENCES, INC. on the open market
Open‑market purchase worth $4.93M — a major conviction buy. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 6/4/2024ACC: 0002007919-24-000006
+286.79K
Net shares
Net buyer
$4.93M
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
286.79K acquired
Non-Derivative Transactions5
Common Stock
Indirect
Shares
+70.19K
Price / share
$16.14
Trade value
$1.13M
% of position
8.7%
5/31/2024
806.08K→876.27K
Common Stock
Indirect
Shares
+46.79K
Price / share
$16.61
Trade value
$777.22K
% of position
5.3%
6/3/2024
876.27K→923.06K
Common Stock
Indirect
Shares
+80.74K
Price / share
$17.90
Trade value
$1.45M
% of position
8.7%
6/3/2024
923.06K→1M
Common Stock
Indirect
Shares
+65.34K
Price / share
$17.44
Trade value
$1.14M
% of position
6.5%
6/4/2024
1M→1.07M
Common Stock
Indirect
Shares
+23.73K
Price / share
$18.24
Trade value
$432.76K
% of position
2.2%
6/4/2024
1.07M→1.09M
Total
Net shares
+286.79K
Net value
$4.93M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/31/2024 | P · Purchase | +70.19K | $16.14 | $1.13M | 8.7% | 806.08K | 876.27K |
| Common Stock Indirect | 6/3/2024 | P · Purchase | +46.79K | $16.61 | $777.22K | 5.3% | 876.27K | 923.06K |
| Common Stock Indirect | 6/3/2024 | P · Purchase | +80.74K | $17.90 | $1.45M | 8.7% | 923.06K | 1M |
| Common Stock Indirect | 6/4/2024 | P · Purchase | +65.34K | $17.44 | $1.14M | 6.5% | 1M | 1.07M |
| Common Stock Indirect | 6/4/2024 | P · Purchase | +23.73K | $18.24 | $432.76K | 2.2% | 1.07M | 1.09M |
| Total | +286.79K | $4.93M | ||||||
Derivative Transactions0
No derivative transactions reported